Kezar Life Sciences Inc (KZR) earnings · $53.9M cap
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
This KZR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
When the next KZR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full KZR research stays on the stock page; the tape stays on the quote page.
Not investment advice.